Just over two years oxford ivermectin study 56 The biotechnology company said a mid-stage study of itsexperimental brain cancer vaccine used in combination withstandard treatments showed a 160 percent increase in progressionfree survival, compared to the standard treatment alone, inpatients with an aggressive brain tumor.
客戶服務,
最新消息
